Scientists test 'Living Drug' for stubborn arthritis
Disease control
Recruiting now
This is an early-stage study testing a new type of cell therapy called ADI-001 for adults with rheumatoid arthritis that hasn't improved with standard treatments. The main goal is to check the safety and side effects of the treatment. Researchers will give participants specially …
Phase: PHASE1 • Sponsor: Adicet Therapeutics • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC